Skip to main content
main-content
Top

08-15-2018 | Pregnancy | Review | Article

Inpatient Glycemic Management of the Pregnant Patient

Journal: Current Diabetes Reports

Authors: Tiffany Yeh, Michele Yeung, Felicia A. Mendelsohn Curanaj

Publisher: Springer US

share
SHARE

Abstract

Purpose of Review

There is a rising prevalence of type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes (GDM) in pregnancy. Reaching and maintaining glycemic targets during and after this time are important for both the health of the mother and her baby.

Recent Findings

Based on recently published guidelines from various societies, we review the diagnosis of diabetes in pregnancy, types of therapies available to maintain euglycemia, important keys to management of T1DM, T2DM, and GDM, and strategies for reaching inpatient glycemic targets during the peripartum period. Care for pregnant patients with T1DM is especially challenging, and providers should be aware of the varying insulin requirements at different stages of pregnancy and how to reduce hypoglycemia and avoid diabetic ketoacidosis. Insulin sensitivity fluctuates throughout pregnancy due to physiologic changes, especially during labor and delivery and immediately post-partum. We review recommendations regarding how to manage this dynamic time and present our own institution’s inpatient management protocol. Finally, we review management of diabetes post-partum, including medications, breast-feeding, and continued monitoring and screening.

Summary

With the collaborative efforts of the patient and an interdisciplinary team and in-depth knowledge of the most up-to-date management principles, it is possible to achieve euglycemia during this critical time of a mother and baby’s life.
Literature
1.
•• Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49–64. The latest guidelines on the management of gestational diabetes in pregnancy from the American College of Obstetricians and Gynecologists. CrossRef
2.
Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19(5):514–41. CrossRefPubMed
3.
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290–6. CrossRefPubMed
4.
Lawlor DA, Fraser A, Lindsay RS, Ness A, Dabelea D, Catalano P, et al. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia. 2010;53(1):89–97. CrossRefPubMed
5.
•• Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227–49. The latest guidelines on diabetes management in pregnancy from the Endocrine Society. CrossRefPubMed
6.
Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of Glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660–8. CrossRefPubMedPubMedCentral
7.
Harmon KA, Gerard L, Jensen DR, Kealey EH, Hernandez TL, Reece MS, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care. 2011;34:2198–204. CrossRefPubMedPubMedCentral
8.
Coombs CA, Moses RG. Aiming at new targets to achieve Normoglycemia during pregnancy. Diabetes Care. 2011;34(10):2331–2. CrossRef
9.
Shields, L and Tsay, GS. Editors, California Diabetes and Pregnancy Program Sweet Success Guidelines for Care. Developed with California Department of Public Health; Maternal Child and Adolescent Health Division; revised edition, updated September 2015.
10.
Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care. 2001;24(7):1130–6. CrossRefPubMed
11.
•• ADA 13. Management of Diabetes in Pregnancy. Diabetes Care. 2018;41(Suppl 1):S137–S43. The latest guidelines on diabetes management in pregnancy from the American Diabetes Association.
12.
• Garrison EA, Jagasia S. Inpatient management of women with gestational and pregestational diabetes in pregnancy. Curr Diab Rep. 2014;14(2):457. A comprehensive review of inpatient gestational diabetes management in 2014. CrossRefPubMed
13.
Hashimoto K, Masafumi K. Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World J Diabetes. 2015;6(8):1045–56. CrossRefPubMedPubMedCentral
14.
Ozgu-Erdinc AS, Iskender C, Uygur D, Oksuzoglu A, Seckin KD, Yeral MI, et al. One-hour versus two-hour postprandial blood glucose measurement in women with gestational diabetes mellitus: which is more predictive? Endocrine. 2016;52(3):561–70. CrossRefPubMed
15.
Moses RG, Lucas EM, Knights S. Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored? Aust NZ J Obstet Gynaecol. 1999;39(4):457–60. CrossRef
16.
Goedegebure EAR, Koning SH, Hoogenberg K, Korteweg FJ, Lutgers HL, Diekman MJM, et al. Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicenter retrospective cohort study. BMC Pregnancy Childbirth. 2018;18:152. CrossRefPubMedPubMedCentral
17.
ADA 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2018;41(Suppl 1):S137–S43.
18.
Lee GT, Satyan MT, Grothusen JD, et al. A retrospective study comparing outcomes in a midwestern US population after introduction of IADPSG guidelines for gestational diabetes. J Matern Fetal Neonatal Med. 2017; Sep 6:1–6.
19.
Hernandez TL, Anderson MA, Chartier-Logan C, Friedman JE, Barbour LA. Strategies in the nutritional management of gestational diabetes. Clin Obstet Gynecol. 2013;56(4):803–15. CrossRefPubMedPubMedCentral
20.
Colberg SR, Castorino K, Jovanovic L. Prescribing physical activity to prevent and manage gestational diabetes. World J Diabetes. 2013;4(6):256–62. CrossRefPubMedPubMedCentral
21.
• Blum AK. Insulin use in pregnancy: an update. Diabetes Spectr. 2016;29(2):92–7. A comprehensive summary of the use of insulins in pregnancy. CrossRefPubMedPubMedCentral
22.
Food and Drug Administration (FDA). Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling. 79 FR 72063. https://​www.​federalregister.​gov/​d/​2014-28241.
23.
Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med. 2008;25(2):165–9. CrossRefPubMed
24.
Vague P, Selam JL, Skeie S, De Leeuw I, et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care. 2003;26(3):590–6. CrossRefPubMed
25.
Okeigwe I, Yeaton-Massey A, Kim S, Vargas JE, Murphy EJ. U-500R and aspart insulin for the treatment of severe insulin resistance in pregnancy associated with pregestational diabetes. J Perinatol. 2013;33(3):235–8. CrossRefPubMed
26.
Zuckerwise LC, Werner EF, Pettker CM, McMahon-Brown EK, Thung SF, Han CS. Pregestational diabetes with extreme insulin resistance: use of U-500 insulin in pregnancy. Obstet Gynecol. 2012;120(2 Pt 2):439–42. CrossRefPubMed
27.
• Kalra B, Gupta Y, Singla R, Kalra S. Use of Oral Anti-Diabetic Agents in Pregnancy: A Pragmatic Approach. N Am J Med Sci. 2015;7(1):6–12. An evidence-based review of oral anti-diabetic agents and their use in pregnancy. CrossRefPubMedPubMedCentral
28.
Rowan JA, Hague WM, Gao W, Battin MR. Moore MP; MiG trial investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15. CrossRefPubMed
29.
Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2013;8(5):e64585. CrossRefPubMedPubMedCentral
30.
•• Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med. 2017;34:27–36. A meta-analysis that showed that metformin had no short-term adverse effects on pregnancy. CrossRefPubMed
31.
Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005;192(1):134–9. CrossRefPubMed
32.
Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–8. CrossRefPubMed
33.
Song R, Chen L, Chen Y, Si X, Liu Y, Liu Y, et al. Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2017;12:e0182488. CrossRefPubMedPubMedCentral
34.
•• Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102. A meta-analysis showing that when treating women with gestational diabetes, glibenclamide (glyburide) is inferior to both insulin and metformin. CrossRefPubMedPubMedCentral
35.
Vargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstet Gynecol. 2010;3(3):92–100. PubMedPubMedCentral
36.
• Modi A, Agrawal A, Morgan F. Euglycemic Diabetic Ketoacidosis: A Review. Curr Diabetes Rev. 2017;13(3):315–21. An article reviewing the etiologies, pathophysiology, diagnosis and management of euglycemic DKA. CrossRefPubMed
37.
Rawla P, Vellipuram AR, Bandaru SS, Pradeep RJ. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017;2017
38.
New York–Presbyterian Hospital. Diabetic Ketoacidosis Guidelines. New York, NY, NewYork–Presbyterian Hospital, Cornell Campuses, June 2017.
39.
McCarthy FP, Lutomski JE, Greene RA. Hyperemesis gravidarum: current perspectives. Int J Womens Health. 2014;6:719–25. PubMedPubMedCentral
40.
London V, Grube S, Sherer DM, Abulafia O. Hyperemesis Gravidarum: a review of recent literature. Pharmacology. 2017;100:161–71. CrossRefPubMed
41.
Feldman AZ, Brown FM. Management of Type 1 diabetes in pregnancy. Curr Diab Rep. 2016;16(8):76. CrossRefPubMedPubMedCentral
42.
Frise CJ, Mackillop L, Joash K, Williamson C. Starvation ketoacidosis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2013;167(1):1–7. CrossRefPubMed
43.
Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the FreeStyle libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther. 2018;20(3):180–8. CrossRefPubMedPubMedCentral
44.
New York–Presbyterian Hospital. Insulin Pump, Patient’s Own, Adult. New York, NY, NewYork–Presbyterian Hospital, Cornell Campuses, June 2017.
45.
Dude A, Niznik CM, Szmuilowicz ED, Peaceman AM, Yee LM. Management of diabetes in the intrapartum and postpartum patient. Am J Perinatol. 2018.
46.
Achong N, Duncan EL, McIntyre HD, Callaway L. Peripartum management of glycemia in women with type 1 diabetes. Diabetes Care. 2014;37(2):364–71. CrossRefPubMed
47.
Drever E, Tomlinson G, Bai AD, Feig DS. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study. Diabet Med. 2016;33(9):1253–9. CrossRefPubMed
48.
New York–Presbyterian Hospital. Insulin Infusion During the Peripartum Period. New York, NY, NewYork–Presbyterian Hospital, Cornell Campuses, June 2017.
49.
ADA 14: Diabetes Care in the Hospital: Standards of Medical Care in Diabetes – 2018. Diabetes Care 2018 Jan; 41(Supplement 1): S144-S151.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

ADA 2022 coverage

Access the latest news and expert insight from the ADA 82nd Scientific Sessions